Oak Harvest Investment Services Amgen Inc Transaction History

Oak Harvest Investment Services

$588 Million
Q2 2024

A detailed history of Oak Harvest Investment Services transactions in Amgen Inc stock. As of the latest transaction made, Oak Harvest Investment Services holds 35,954 shares of AMGN stock, worth $11.5 Million. This represents 1.91% of its overall portfolio holdings.

Number of Shares

35,954

Previous 38,067 5.55%

Holding current value

$11.5 Million

Previous $10.8 Million 3.79%

% of portfolio

1.91%

Previous 1.87%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$262.75 - $319.31 $555,190 - $674,702	-2,113 Reduced 5.55%	35,954 $11.2 Million
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $1.64 Million - $1.99 Million	6,116 Added 19.14%	38,067 $10.8 Million
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $250,586 - $282,690	-980 Reduced 2.98%	31,951 $9.2 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $2.48 Million - $3.08 Million	11,338 Added 52.51%	32,931 $8.85 Million
Q2 2023 Jul 17, 2023	BUY	$214.27 - $253.37 $3.45 Million - $4.08 Million	16,091 Added 292.46%	21,593 $4.79 Million
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $1.07 Million - $1.3 Million	4,733 Added 615.47%	5,502 $1.33 Million
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $176,124 - $223,786	769 New	769 $0
Q3 2021 Oct 08, 2021	SELL	$212.27 - $248.7 $2.83 Million - $3.32 Million	-13,355 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$233.58 - $259.14 $12,846 - $14,252	-55 Reduced 0.41%	13,355 $3.26 Million
Q1 2021 Apr 12, 2021	SELL	$221.91 - $258.6 $621,348 - $724,080	-2,800 Reduced 17.27%	13,410 $3.34 Million
Q4 2020 Jan 15, 2021	BUY	$216.38 - $257.67 $3.51 Million - $4.18 Million	16,210 New	16,210 $3.73 Million

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Harvest Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on Oak Harvest Investment Services with notifications on news.

Account

Oak Harvest Investment Services Amgen Inc Transaction History